Cart
sales@molnova.com
Propitocaine hydrochloride
CAS No. 1786-81-8
Propitocaine hydrochloride( —— )
Catalog No. M12692 CAS No. 1786-81-8
Prilocaine hydrochloride is a local anesthetic of the amino amide type.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 34 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | 64 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePropitocaine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPrilocaine hydrochloride is a local anesthetic of the amino amide type.
-
DescriptionPrilocaine hydrochloride is a local anesthetic of the amino amide type.(In Vitro):Prilocaine is more potent in inhibiting the Na,K-ATPase of plasma membranes of LM cells (transformed fibroblasts) at 37 ℃ (43.8 mM) than at 25 ℃ (28.2 mM).
-
In VitroPrilocaine hydrochloride is more potent in inhibiting the Na,K-ATPase of plasma membranes of LM cells (transformed fibroblasts) at 37 ℃ (43.8 mM) than at 25 ℃ (28.2 mM).
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1786-81-8
-
Formula Weight256.77
-
Molecular FormulaC13H21ClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCl.CCCNC(C)C(=O)NC1=CC=CC=C1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dimri M, et al. Tokai J Exp Clin Med. 2015 Mar 20;40(1):8-15.
molnova catalog
related products
-
Ranolazine dihydroch...
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
Trapencaine
Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
Huwentoxin IV
Selective NaV1.7 channel blocker. Preferentially inhibits neuronal NaV1.7, 1.2 and 1.3 (IC50 values are 26, 150 and 338 nM respectively), compared to muscle subtypes NaV1.4 and 1.5 (IC50 = >10 μM). Inhibits the channel by binding at the neurotoxin receptor site 4 in the S3-S4 linker of domain II, trapping the voltage sensor in the inward, closed configuration.
